LeadIQ logo
Learn more at LeadIQ.com

Insights

Growth Potential Xcovery is a rapidly evolving biopharmaceutical company with a recent FDA approval for its lead product ensartinib, highlighting a significant market entry opportunity in the oncology space targeted at non-small cell lung cancer (NSCLC) patients.

Innovative Pipeline With a focus on developing advanced cancer therapies, Xcovery's pipeline presents potential upsell or partnership opportunities with healthcare providers and biotech firms seeking cutting-edge oncology solutions.

Funding Strength Having secured $20 million in funding and generating revenue between $1 million and $10 million, Xcovery is positioned to expand its sales network and increase outreach to hospitals and clinics involved in cancer treatment.

Market Differentiation Xcovery’s recent FDA approval for ensartinib differentiates it from competitors by establishing the company as a credible and innovative player in targeted cancer therapies, opening doors for strategic collaborations.

Technology Utilization The company’s tech stack and digital presence suggest a focus on data-driven marketing and outreach, providing opportunities to leverage digital channels for engaging healthcare professionals and expanding market reach.

Xcovery Holdings, Inc. Tech Stack

Xcovery Holdings, Inc. uses 8 technology products and services including Open Graph, Font Awesome, Google Cloud, and more. Explore Xcovery Holdings, Inc.'s tech stack below.

  • Open Graph
    Content Management System
  • Font Awesome
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Backbone.js
    Javascript Frameworks
  • yepnope.js
    Javascript Frameworks
  • Underscore.js
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Google Analytics
    Web Analytics

Xcovery Holdings, Inc.'s Email Address Formats

Xcovery Holdings, Inc. uses at least 1 format(s):
Xcovery Holdings, Inc. Email FormatsExamplePercentage
First@xcovery.comJohn@xcovery.com
67%
First.Last@xcovery.comJohn.Doe@xcovery.com
18%
F.Last@xcovery.comJ.Doe@xcovery.com
8%
FLast@xcovery.comJDoe@xcovery.com
7%

Frequently Asked Questions

Where is Xcovery Holdings, Inc.'s headquarters located?

Minus sign iconPlus sign iconXcovery Holdings, Inc.'s main headquarters is located at 168 Southeast 1st Street Suite 1100 Miami, Florida 33131 United States. The company has employees across 1 continents, including North America.

What is Xcovery Holdings, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Xcovery Holdings, Inc.'s main corporate office by phone at
+1-561-355-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Xcovery Holdings, Inc.'s official website and social media links?

Minus sign iconPlus sign iconXcovery Holdings, Inc.'s official website is xcovery.com and has social profiles on LinkedInCrunchbase.

How much revenue does Xcovery Holdings, Inc. generate?

Minus sign iconPlus sign icon As of March 2026, Xcovery Holdings, Inc.'s annual revenue is estimated to be $1.4M.

What is Xcovery Holdings, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconXcovery Holdings, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Xcovery Holdings, Inc. have currently?

Minus sign iconPlus sign iconAs of March 2026, Xcovery Holdings, Inc. has approximately 19 employees across 1 continents, including North America. Key team members include Vice President Oncology: J. G.Vice President Operations: E. S.Chairman/Ceo: S. G. S.. Explore Xcovery Holdings, Inc.'s employee directory with LeadIQ.

What industry does Xcovery Holdings, Inc. belong to?

Minus sign iconPlus sign iconXcovery Holdings, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Xcovery Holdings, Inc. use?

Minus sign iconPlus sign iconXcovery Holdings, Inc.'s tech stack includes Open GraphFont AwesomeGoogle CloudBackbone.jsyepnope.jsUnderscore.jsjQuery MigrateGoogle Analytics.

What is Xcovery Holdings, Inc.'s email format?

Minus sign iconPlus sign iconXcovery Holdings, Inc.'s email format typically follows the pattern of First@xcovery.com. Find more Xcovery Holdings, Inc. email formats with LeadIQ.

How much funding has Xcovery Holdings, Inc. raised to date?

Minus sign iconPlus sign icon As of March 2026, Xcovery Holdings, Inc. has raised $20M in funding. The last funding round occurred on Oct 29, 2014 for $20M.

When was Xcovery Holdings, Inc. founded?

Minus sign iconPlus sign iconXcovery Holdings, Inc. was founded in 2006.

Xcovery Holdings, Inc.

Pharmaceutical ManufacturingFlorida, United States11-50 Employees

Xcovery is a biopharmaceutical company with the aim to improve the lives of cancer patients by discovering and developing innovative medicines to fight advanced tumors. We are working on a pipeline of oncology therapies to target a wide range of malignant diseases.

On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not previously received an ALK-inhibitor.

Full prescribing information for Ensacove will be posted on Drugs@FDA.

Section iconCompany Overview

Headquarters
168 Southeast 1st Street Suite 1100 Miami, Florida 33131 United States
Phone number
+1-561-355-****
Website
xcovery.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2006
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $20M

    Xcovery Holdings, Inc. has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Oct 29, 2014 in the amount of $20M.

  • $10M$25M

    Xcovery Holdings, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $20M

    Xcovery Holdings, Inc. has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Oct 29, 2014 in the amount of $20M.

  • $10M$25M

    Xcovery Holdings, Inc.'s revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    J. G.
    Vice President Oncology
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. S.
    Vice President Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. G. S.
    Chairman/Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. L.
    Executive Vice President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. S.
    National Director, Head Of Field Medical
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    C. M.
    Sr Vp, Finance & Administration
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. B.
    Financial Controller
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. D.
    Clinical Trial Document Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. C.
    Quality Assurance Compliance Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. M.
    Senior Qa Document Control Specialist
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.